Your cart is empty.
This is an adult-oriented lecture presented during our DNA Fest.
2:00 - 2:30pm: Lecture by Matt Might
Matt Might will tell his story of rare disease and the promise of precision medicine.
2:30 - 3:00pm: Panel discussion and audience Q/A session
The visiting public will have the opportunity to ask questions about DNA sequencing, genetics research, genomic medicine, undiagnosed disease, etc.
Panel Discussion Participants
Will Dere, MD, FACP (Moderator)
Dr. Dere is Professor of Medicine and Executive director of the Program in Personalized Health at the University of Utah Health Sciences. With 25 years experience in the biopharmaceutical industry, Dr. Dere is a recognized leader in translating genomic discovery to improve clinical care. He is building on the strengths of University of Utah and the Utah Genome Project to customize treatments to the individual patient.
Matt Might, PhD
Dr. Might is an Associate Professor in the School of Computing at the University of Utah; an Associate Professor, Visiting, at the Harvard Medical School; and a Strategist in the Executive Office of the President at the White House. Dr. Might's son Bertrand was the first patient ever diagnosed with the ultra-rare genetic disorder NGLY1 deficiency. As a result, his work in medicine focuses on bringing the promise of precision/genomic medicine to the clinic for today's patients.
Karin Dent, MS, CGC
Karin Dent is a certified and licensed Genetic Counselor and Associate Professor in the Department of Pediatrics at the University of Utah. Karin provides genetic counseling at Primary Children’s Hospital and in the Motor Neuron Disease clinics at the University of Utah Medical Center. Her research interests include the delivery of difficult news by healthcare providers, and the ethical challenges surrounding informed consent and return of results genome sequencing research.
Steven Bleyl, MD, PhD
Dr. Bleyl is Associate Professor of Pediatrics at the University of Utah Health Sciences and also sees patients through Intermountain Health Care. Dr. Bleyl’s clinical practice and his research focuses on the genetic basis for congenital heart defects, which affect as many as 1 in 100 live born children and weigh heavily on society both in their effect on society and in their impact on patients and families.
Sean Tavtigian, PhD
Sean V. Tavtigian, PhD, is Professor of Oncological Sciences at the University of Utah and a Huntsman Cancer Institute investigator. He is a co-leader of the Cancer Control and Population Sciences Program. Dr. Tavtigian's research focuses on cancer susceptibility genes and genetic variants.